Molly A. O'Gorman
No Rating Available
(Learn About Our Rating System)

Molly A. O'Gorman, MD

Languages spoken: English

Clinical Locations

Eccles Primary Children's Outpatient Services

Salt Lake City
801-213-3599

Primary Children's Hospital Outpatient Services at Riverton

Riverton
801-213-3599

  • Molly A. O’Gorman, M.D. is a Professor of Pediatric Gastroenterology, Hepatology, and Nutrition at the University of Utah. She is the Medical Director of the Pediatric Dysphagia Program and of the EDDIE Clinic (Elimination Disorders, Diagnosis of Incontinence and Encopresis) at Primary Children’s Medical Center. Dr. O’Gorman received her M.D. degree from State University of New York. She completed her pediatric residency at Children’s Hospital of Pittsburgh and her pediatric gastroenterology fellowship at Johns Hopkins University. She is board certified in pediatric gastroenterology and is a member of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHN). She also is a member of the American Parnership for Eosinophilic Diseases (APFED). Dr. O’Gorman has great interest in eosinophilic gastrointestinal diseases and is conducting clinical research in the disorder of eosinophilic esophagitis. She also is involved in the Pediatric Liver Transplant program directed by Linda S. Book, M.D. and continues to see in- and out-patients with complicated liver diseases.

    Specialties

  • Molly A. O’Gorman, M.D. is a Professor of Pediatric Gastroenterology, Hepatology, and Nutrition at the University of Utah. She is the Medical Director of the Pediatric Dysphagia Program and of the EDDIE Clinic (Elimination Disorders, Diagnosis of Incontinence and Encopresis) at Primary Children’s Medical Center. Dr. O’Gorman received her M.D. degree from State University of New York. She completed her pediatric residency at Children’s Hospital of Pittsburgh and her pediatric gastroenterology fellowship at Johns Hopkins University. She is board certified in pediatric gastroenterology and is a member of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHN). She also is a member of the American Parnership for Eosinophilic Diseases (APFED). Dr. O’Gorman has great interest in eosinophilic gastrointestinal diseases and is conducting clinical research in the disorder of eosinophilic esophagitis. She also is involved in the Pediatric Liver Transplant program directed by Linda S. Book, M.D. and continues to see in- and out-patients with complicated liver diseases.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Gastroenterology, Hepatology, & Nutrition

    Education history

    Fellowship Pediatric Gastroenterology - John Hopkins University, Department of Environmental Health Fellow
    Pediatrics - Children's Hospital of Pittsburgh Resident
    Professional Medical State University of New York M.D.
    Natural Science - Roswell Park Memorial Institute M.S.
    Undergraduate Biology - Ithaca College B.A.

    Selected Publications

    Journal Article

    1. Benninga MA, Hussain SZ, Sood MR, Nurko S, Hyman P, Clifford RA, OGorman M, Losch-Beridon T, Mareya S, Lichtlen P, Di Lorenzo C (2021). Lubiprostone for Pediatric Functional Constipation: Randomized, Controlled, Double-Blind Study With Long-term Extension. Clin Gastroenterol Hepatol, 20(3), 602-610.e5. (Read full article)
    2. McClain A, OGorman M, Barbagelata C, Patel R, Lowichik A, Peterson K, Guthery S, Robson J (2020). Adherence to Biopsy and Follow-Up Guidelines in a Population-Based Cohort of Children With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol, 18(11), 2620-2622.
    3. McClain A, OGorman M, Barbagelata C, Patel R, Lowichik A, Peterson K, Guthery S, Robson J (2019). Adherence to Biopsy and Follow-Up Guidelines in a Population-Based Cohort of Children With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol, 18(11), 2620-2622. (Read full article)
    4. Casazza GC, Graham ME, Asfour F, OGorman M, Skirko J, Meier JD (2019). Aspiration in the otherwise healthy Infant-Is there a natural course for improvement? Laryngoscope, 130(2), 514-520. (Read full article)
    5. Robson J, Korgenski K, Parsons K, McClain A, Barbagelata C, Allen-Brady K, Patel R, OGorman M, Peterson K, Guthery S (2019). Sensitivity and Specificity of Administrative Medical Coding for Pediatric Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr, 69(2), e49-e53.
    6. Robson J, Korgenski K, Parsons K, McClain A, Barbagelata C, Allen-Brady K, Patel R, OGorman M, Peterson K, Guthery S (2019). Sensitivity and Specificity of Administrative Medical Coding for Pediatric Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr, 69(2), e49-e53. (Read full article)
    7. Robson J, Laborda T, Fitzgerald S, Andersen J, Peterson K, OGorman M, Guthery S, Bennett-Murphy L (2019). Avoidant/Restrictive Food Intake Disorder in Diet-treated Children With Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr, 69(1), 57-60.
    8. Robson J, Laborda T, Fitzgerald S, Andersen J, Peterson K, OGorman M, Guthery S, Bennett-Murphy L (2019). Avoidant/Restrictive Food Intake Disorder in Diet-treated Children With Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr, 69(1), 57-60. (Read full article)
    9. Robson J, OGorman M, McClain A, Mutyala K, Davis C, Barbagelata C, Wheeler J, Firszt R, Smith K, Patel R, Peterson K, Lowichik A, Guthery S (2019). Incidence and Prevalence of Pediatric Eosinophilic Esophagitis in Utah Based on a 5-Year Population-Based Study. Clin Gastroenterol Hepatol, 17(1), 107-114.e1.
    10. Robson J, OGorman M, McClain A, Mutyala K, Davis C, Barbagelata C, Wheeler J, Firszt R, Smith K, Patel R, Peterson K, Lowichik A, Guthery S (2018). Incidence and Prevalence of Pediatric Eosinophilic Esophagitis in Utah Based on a 5-Year Population-Based Study. Clin Gastroenterol Hepatol, 17(1), 107-114.e1. (Read full article)